scholarly journals Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

2007 ◽  
Vol 117 (12) ◽  
pp. 3846-3856 ◽  
Author(s):  
Sizhi Paul Gao ◽  
Kevin G. Mark ◽  
Kenneth Leslie ◽  
William Pao ◽  
Noriko Motoi ◽  
...  
Keyword(s):  
Human Lung ◽  
Kinase Domain ◽  
Lung Adenocarcinomas ◽  
Egfr Kinase

scholarly journals Comparable rate of EGFR kinase domain mutation in lung adenocarcinomas from Chinese male and female never-smokers

2010 ◽  
Vol 31 (5) ◽  
pp. 647-648 ◽  
Author(s):  
Yi-hua Sun ◽  
Rong Fang ◽  
Bin Gao ◽  
Xiang-kun Han ◽  
Jun-hua Zhang ◽  
...  
Keyword(s):  
Kinase Domain ◽  
Comparable Rate ◽  
Male And Female ◽  
Kinase Domain Mutation ◽  
Never Smokers ◽  
Lung Adenocarcinomas ◽  
Chinese Male ◽  
Egfr Kinase

scholarly journals Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

PLoS Medicine ◽  
2005 ◽  
Vol 2 (3) ◽  
pp. e73 ◽  
Author(s):  
William Pao ◽  
Vincent A Miller ◽  
Katerina A Politi ◽  
Gregory J Riely ◽  
Romel Somwar ◽  
...  
Keyword(s):  
Acquired Resistance ◽  
Kinase Domain ◽  
Lung Adenocarcinomas ◽  
Egfr Kinase

scholarly journals Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Zhenfang Du ◽  
Benjamin P. Brown ◽  
Soyeon Kim ◽  
Donna Ferguson ◽  
Dean C. Pavlick ◽  
...  
Keyword(s):  
Tandem Duplication ◽  
Function Analysis ◽  
Treatment Strategies ◽  
Kinase Domain ◽  
Time Resolved ◽  
Egfr Activation ◽  
Domain Duplication ◽  
Activation Mechanisms ◽  
Potential Therapeutic Intervention ◽  
Egfr Kinase

AbstractMechanistic understanding of oncogenic variants facilitates the development and optimization of treatment strategies. We recently identified in-frame, tandem duplication of EGFR exons 18 - 25, which causes EGFR Kinase Domain Duplication (EGFR-KDD). Here, we characterize the prevalence of ERBB family KDDs across multiple human cancers and evaluate the functional biochemistry of EGFR-KDD as it relates to pathogenesis and potential therapeutic intervention. We provide computational and experimental evidence that EGFR-KDD functions by forming asymmetric EGF-independent intra-molecular and EGF-dependent inter-molecular dimers. Time-resolved fluorescence microscopy and co-immunoprecipitation reveals EGFR-KDD can form ligand-dependent inter-molecular homo- and hetero-dimers/multimers. Furthermore, we show that inhibition of EGFR-KDD activity is maximally achieved by blocking both intra- and inter-molecular dimerization. Collectively, our findings define a previously unrecognized model of EGFR dimerization, providing important insights for the understanding of EGFR activation mechanisms and informing personalized treatment of patients with tumors harboring EGFR-KDD. Finally, we establish ERBB KDDs as recurrent oncogenic events in multiple cancers.

scholarly journals Clinical outcomes of EGFR kinase domain duplication to targeted therapies in NSCLC

2018 ◽  
Vol 144 (11) ◽  
pp. 2677-2682 ◽  
Author(s):  
Jinguang Wang ◽  
Xingya Li ◽  
Xingyang Xue ◽  
Qiuxiang Ou ◽  
Xue Wu ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Targeted Therapies ◽  
Kinase Domain ◽  
Domain Duplication ◽  
Egfr Kinase

scholarly journals Molecular docking based screening of novel designed chalcone series of compounds for their anti-cancer activity targeting EGFR kinase domain

2015 ◽  
Vol 11 (7) ◽  
pp. 322-329 ◽  
Author(s):  
Chennu Rao ◽  
◽  
Rajendra Prasad Yejella ◽  
Rehman Rehman ◽  
Syed Hussain Basha ◽  
...  
Keyword(s):  
Molecular Docking ◽  
Kinase Domain ◽  
Anti Cancer ◽  
Cancer Activity ◽  
Egfr Kinase

scholarly journals Lung adenocarcinoma patient with an EGFR kinase domain duplication (KDD) and the response to icotinib

2018 ◽  
Vol 10 (5) ◽  
pp. E359-E363 ◽  
Author(s):  
You-Cai Zhu ◽  
Wen-Xian Wang ◽  
Chun-Wei Xu ◽  
Qing-He Tan ◽  
Jian-Ying Li ◽  
...  
Keyword(s):  
Lung Adenocarcinoma ◽  
Kinase Domain ◽  
Domain Duplication ◽  
Lung Adenocarcinoma Patient ◽  
Egfr Kinase

scholarly journals EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment

Oncotarget ◽  
2015 ◽  
Vol 7 (3) ◽  
pp. 3367-3378 ◽  
Author(s):  
Hongjuan Zhang ◽  
Cheng Zhan ◽  
Ji Ke ◽  
Zhiqiang Xue ◽  
Aiqun Zhang ◽  
...  
Keyword(s):  
Kinase Domain ◽  
Lung Cancers ◽  
Hyperthermic Chemotherapy ◽  
Complete Treatment ◽  
Kinase Domain Mutation ◽  
Egfr Kinase

scholarly journals Structural signature of the G719S-T790M double mutation in the EGFR kinase domain and its response to inhibitors

2014 ◽  
Vol 4 (1) ◽  
Author(s):  
George Priya Doss C. ◽  
Rajith B. ◽  
Chiranjib Chakraborty ◽  
NagaSundaram N. ◽  
Shabana Kouser Ali ◽  
...  
Keyword(s):  
Kinase Domain ◽  
Double Mutation ◽  
Structural Signature ◽  
Egfr Kinase

Abstract 867: EGFR kinase domain duplication (EGFR-KDD) is activated by asymmetric intra-molecular dimerization

2019 ◽  
Author(s):  
Zhenfang Du ◽  
Jean-Nicolas Gallant ◽  
Monica Red-Brewer ◽  
Benjamin Brown ◽  
Jonathan Sheehan ◽  
...  
Keyword(s):  
Kinase Domain ◽  
Domain Duplication ◽  
Egfr Kinase
Sign in / Sign up

Export Citation Format

Share Document